Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))

M. Matsuo; H. Sakurai; Y. Ueno; O. Ohtani; I. Saiki

doi:10.1111/j.1349-7006.2006.00187.x

Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))

M. Matsuo, H. Sakurai, Y. Ueno, O. Ohtani, I. Saiki

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	242
Number of pages	1
Journal	Cancer Science
Volume	97
Issue number	3
DOIs	https://doi.org/10.1111/j.1349-7006.2006.00187.x
State	Published - 2006/03

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1349-7006.2006.00187.x

Cite this

@article{cb271217831e4b8d8f77048df36b9f10,

title = "Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))",

author = "M. Matsuo and H. Sakurai and Y. Ueno and O. Ohtani and I. Saiki",

year = "2006",

month = mar,

doi = "10.1111/j.1349-7006.2006.00187.x",

language = "英語",

volume = "97",

pages = "242",

journal = "Cancer Science",

issn = "1347-9032",

publisher = "Wiley-Blackwell",

number = "3",

}

Matsuo, M, Sakurai, H, Ueno, Y, Ohtani, O & Saiki, I 2006, 'Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))', Cancer Science, vol. 97, no. 3, pp. 242. https://doi.org/10.1111/j.1349-7006.2006.00187.x

Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162)). / Matsuo, M.; Sakurai, H.; Ueno, Y. et al.
In: Cancer Science, Vol. 97, No. 3, 03.2006, p. 242.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))

AU - Matsuo, M.

AU - Sakurai, H.

AU - Ueno, Y.

AU - Ohtani, O.

AU - Saiki, I.

PY - 2006/3

Y1 - 2006/3

UR - http://www.scopus.com/inward/record.url?scp=33645992099&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2006.00187.x

DO - 10.1111/j.1349-7006.2006.00187.x

M3 - コメント/討論

AN - SCOPUS:33645992099

SN - 1347-9032

VL - 97

SP - 242

JO - Cancer Science

JF - Cancer Science

IS - 3

ER -